These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11322351)

  • 1. Safety of electrical cardioversion in patients with previous embolic events.
    Elhendy A; Gentile F; Khandheria BK; Bailey KR; Burger KN; Seward JB
    Mayo Clin Proc; 2001 Apr; 76(4):364-8. PubMed ID: 11322351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of spontaneous echocontrast, 'sludge' and thrombi before cardioversion in patients with atrial fibrillation: new insights into the role of transesophageal echocardiography.
    Maltagliati A; Galli CA; Tamborini G; Celeste F; Muratori M; Pepi M
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):523-8. PubMed ID: 19474574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolic complications after electrical cardioversion in patients with atrial flutter.
    Elhendy A; Gentile F; Khandheria BK; Gersh BJ; Bailey KR; Montgomery SC; Seward JB; Tajik AJ
    Am J Med; 2001 Oct; 111(6):433-8. PubMed ID: 11690567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
    Roijer A; Eskilsson J; Olsson B
    Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of electrical cardioversion in patients with atrial fibrillation.
    Gentile F; Elhendy A; Khandheria BK; Seward JB; Lohse CM; Shen WK; Bailey KR; Montgomery SC; Burger KN; Tajik AJ
    Mayo Clin Proc; 2002 Sep; 77(9):897-904. PubMed ID: 12233921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography: a single centre 8.5-year experience.
    Corrado G; Santarone M; Beretta S; Tadeo G; Tagliagambe LM; Foglia-Manzillo G; Spata M; Miglierina E; Acquati F; Santarone M
    Europace; 2000 Apr; 2(2):119-26. PubMed ID: 11225938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Ventricular Function after TEE-guided Cardioversion of Atrial Arrhythmias in Patients after the Fontan Operation.
    Poterucha JT; Egbe AC; Johnson JN; Niaz T; Wackel PL; Cannon BC; Eidem BW; Cetta F
    Congenit Heart Dis; 2016 Dec; 11(6):578-583. PubMed ID: 27030521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies.
    Kinch JW; Davidoff R
    Arch Intern Med; 1995 Jul; 155(13):1353-60. PubMed ID: 7794083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study.
    Seidl K; Rameken M; Drögemüller A; Vater M; Brandt A; Schwacke H; Bergmeier C; Zahn R; Senges J
    J Am Coll Cardiol; 2002 May; 39(9):1436-42. PubMed ID: 11985904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial appendage "stunning" after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events.
    Grimm RA; Stewart WJ; Arheart K; Thomas JD; Klein AL
    J Am Coll Cardiol; 1997 Mar; 29(3):582-9. PubMed ID: 9060897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation).
    Flaker G; Lopes RD; Al-Khatib SM; Hermosillo AG; Hohnloser SH; Tinga B; Zhu J; Mohan P; Garcia D; Bartunek J; Vinereanu D; Husted S; Harjola VP; Rosenqvist M; Alexander JH; Granger CB;
    J Am Coll Cardiol; 2014 Mar; 63(11):1082-7. PubMed ID: 24211508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolism following cardioversion of "common" atrial flutter. Risk factors and limitations of transesophageal echocardiography.
    Mehta D; Baruch L
    Chest; 1996 Oct; 110(4):1001-3. PubMed ID: 8874259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of expedited anticoagulation in patients undergoing transesophageal echocardiographic-guided cardioversion.
    Wu LA; Chandrasekaran K; Friedman PA; Ammash NM; Ramakrishna G; Hart CY; Moon BS; Herges RM; Rosales AG; Malouf JF
    Am J Med; 2006 Feb; 119(2):142-6. PubMed ID: 16443416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of transoesophageal echocardiography before cardioversion in patients with atrial fibrillation and different anticoagulant regimens.
    Maltagliati A; Galli CA; Tamborini G; Calligaris A; Doria E; Salehi R; Pepi M
    Heart; 2006 Jul; 92(7):933-8. PubMed ID: 16284221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials.
    Moreyra E; Finkelhor RS; Cebul RD
    Am Heart J; 1995 Jan; 129(1):71-5. PubMed ID: 7817928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study.
    Manning WJ; Silverman DI; Keighley CS; Oettgen P; Douglas PS
    J Am Coll Cardiol; 1995 May; 25(6):1354-61. PubMed ID: 7722133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter.
    Yadlapati A; Groh C; Passman R
    Am J Cardiol; 2014 Apr; 113(8):1362-3. PubMed ID: 24576547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new therapeutic strategy for electrical cardioversion of atrial fibrillation.
    de Luca I; Sorino M; Del Salvatore B; de Luca L
    Ital Heart J; 2001 Nov; 2(11):831-40. PubMed ID: 11770868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion.
    Gallagher MM; Hennessy BJ; Edvardsson N; Hart CM; Shannon MS; Obel OA; Al-Saady NM; Camm AJ
    J Am Coll Cardiol; 2002 Sep; 40(5):926-33. PubMed ID: 12225717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.